Patent Exclusivity Reform Needed Due To Difficult Drug Environment – Hassan
Executive Summary
The fixed post-approval exclusivity period should be extended in light of the lengthening of the development process, Schering-Plough CEO Fred Hassan suggested during an interview with "The Pink Sheet"